与成人注意力缺陷/多动症治疗期间不良事件相关的费用
Jeff Schein1, Martin Cloutier2, Rebecca Bungay2
1Otsuka Pharmaceutical Development & Commercialization, Inc, Princeton, NJ, USA.
Journal of medical economics
|April 11, 2024
概括
与注意力缺陷/多动症 (ADHD) 药物相关的不良事件 (AEs) 会导致支付人支付大量医疗保健费用. 了解这些成本对于有效管理ADHD治疗至关重要.
科学领域:
- 药物经济学 药物经济学
- 现实世界的证据.
- 医疗保健管理的管理
背景情况:
- 注意力缺陷/多动症 (ADHD) 药物使用是常见的,但相关的不良事件 (AE) 会导致现实世界的成本.
- 关于与ADHD药物相关的副作用相关的医疗保健成本的付款人角度存在有限的数据.
研究的目的:
- 评估与美国成年ADHD患者常见的副作用相关的医疗保健成本.
- 量化AE特异性和每患者每月 (PPPM) 的过度医疗保健成本.
主要方法:
- 使用大型美国索赔数据库 (2015-2021) 进行回顾性队列研究.
- 对461,464名因多动症治疗的成年患者的分析.
- 平衡用于将AE相关成本与非AE事件进行比较.
主要成果:
- 几乎一半的患者 (49.4%) 经历了至少一个AE.
- 显著的AE特定成本从57美元 (勃起功能障碍) 到723美元 (感到紧张).
- 过度的医疗保健费用PPPM从120美元 (勃起功能障碍) 到1,160美元 (感到紧张).
结论:
- 与ADHD治疗相关的副作用导致大量的医疗保健支出.
- 具有更好的安全性概况的治疗可能会减少患者和医疗保健系统的负担.
关键词:
更多关于 ADHD ADHD 的文章治疗ADHD的治疗方法注意力缺陷/多动症障碍 注意力缺陷/多动症我已经开始了,我已经开始了.第111章 这是一件好事一百一十一章 一百一十一章在1919年,我开始了我的生活.不良事件不良事件不良事件经济负担 经济负担治疗期间的治疗情节.更多相关视频
05:48The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
5.7K
13:09Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol
Published on: April 1, 2018
10.3K
相关概念视频
Attention-Deficit/Hyperactivity Disorder
57
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
57
Adrenergic Agonists: Therapeutic Uses
770
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
770
Pharmacovigilance
830
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
830
Drug Therapy
43
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
43
Alzheimer's Disease: Treatment
183
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
183
Oppositional Defiant Disorder
25
A persistent pattern of angry or irritable mood, defiant behavior, or vindictiveness characterizes Oppositional Defiant Disorder (ODD). Symptoms must occur over at least six months, involve interactions with individuals beyond siblings, and meet specific diagnostic criteria to be clinically significant. The disorder affects emotional regulation, social interactions, and behavior, often manifesting early in life and influencing long-term development and functioning.
Diagnostic Criteria and...
Diagnostic Criteria and...
25
